Commercial availability begins June 2026

micro photobiomodulation modules for commerical healthwear

Meet Our Team Request Technical Overview
COMMERCIAL AVAILABILITY BEGINS JUNE 2026
FDA-pathway-aligned photobiomodulation (PBM) modules and control infrastructure enabling apparel, healthcare, and performance brands to deploy regulated pain and recovery solutions at scale. 

Wearable by Design

Built for textile and wearable integration

Evidence-Based

Designed to meet FDA 510(k) predicate parameters

Intelligent Light Dosing

Licensed B2B • Scalable manufacturing • Controlled dosing

FDA-pathway-aligned PBM modules 

Feel the difference we deliver therapy, not just data

As of June, Niraxx enables partners to move beyond pilots and R&D into regulated commercial deployment. 

Our X1 Micro PBM Module is engineered for integration into garments, sleeves, wraps, and uniforms — supported by a control layer that governs dosing, safety, and consistency across real-world use.

This milestone marks the transition from experimental photobiomodulation to scalable healthwear infrastructure.

 

start partner evaluation

what Niraxx Provides

X1 Micro PBM Module 

‣ Targeted wavelength and irradiance profiles

‣ Thermal and duty-cycle safety controls 

‣ Flexible for factors for apparel and medical use 

‣ FDA pathway alignment for musculoskeletal pain 

Control Layer Infrastructure 

Firmware and system logic that transforms PBM from a session-based therapy into a governed, repeatable intervention.
 

‣ Dosing logic and timing control

‣ BLE-enabled orchestration

‣ Consistency across users and environments 

‣ Foundation for closed-loop expansion 

the tech: clinical science. wearable form.

Built for Commercial Partners 

Apparel & Activewear Brands

Launch differentiated recovery and pain solutions without building hardware, firmware, or regulatory systems internally.

Healthcare & Medical Distributors

Deploy wearable PBM products that support adherence, safety, and real-world usability.

Sports & Performance Organizations

Integrate recovery and pain-management capabilities into daily-use gear aligned with performance workflows.

designed for regulated deployment

Niraxx modules are engineered with regulatory discipline from the outset.

  • Predicate-aligned design for FDA 510(k) submission
  • Hardware- and firmware-level thermal safeguards
  • Controlled dosing profiles and session governance
  • Design controls compatible with partner compliance needs

Our regulatory strategy is intended to reduce risk for partners while enabling long-term category scale.
View regulatory & Safety overview

building the future

Partner Onboarding Now Underway

Niraxx is actively onboarding commercial partners for June and post-June deployment.
 
Partner engagement typically includes:
 
  • Technical evaluation and integration planning
  • Module and system validation
  • Pilot or limited commercial rollout
  • Scale-up planning for manufacturing and distribution

 

start partner evaluation

about Niraxx

Niraxx develops photonic modulation infrastructure for healthwear — bridging regulated medical technology with scalable textile and wearable systems.
 
Rooted in clinical research and engineered for manufacturing reality, Niraxx provides the missing control layer that enables wearable products to move from measurement to intervention.

our research partners

We work with world-class research institutions to advance our science. Our partners include Harvard University and Mass General Hospital (MGH). MGH Psychiatry has consistently been ranked #1 in US News & World Report.

Niraxx is selectively engaging commercial, strategic, and institutional partners to support manufacturing scale and global deployment.

5151 California Ave. Suite 100
Irvine, CA 92617

care@niraxx.com

Main Pages

Quick Links

Social Media

Please join our social media to find out the latest news/updates.

Copyright © 2016-2024 Niraxx, Inc. All Rights Reserved